Why it was recalled
Lack of Assurance of Sterility
Product description
NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.
Lot numbers, UPCs & expiration codes
Lot#: 07192307A2, BUD: 11/18/2023
Where it was sold
Nationwide within the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1106-2023
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Aug 15, 2023
- FDA report date
- Aug 30, 2023
- Quantity
- 99 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- TMC Acquisitions LLC dba Tailor Made Compounding
Original FDA data
Every field from FDA enforcement report D-1106-2023, exactly as published.
Show all FDA fields
- City
- Nicholasville
- State
- KY
- Status
- Terminated
- Country
- United States
- Event ID
- 92896
- Address
- 200 Moore Dr
- Code information
- Lot#: 07192307A2, BUD: 11/18/2023
- Postal code
- 40356-8512
- Report date
- Aug 30, 2023
- Product type
- Drugs
- Recall number
- D-1106-2023
- Classification
- Class II
- Recalling firm
- TMC Acquisitions LLC dba Tailor Made Compounding
- Product quantity
- 99 vials
- Termination date
- Sep 30, 2024
- Reason for recall
- Lack of Assurance of Sterility
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.
- Distribution pattern
- Nationwide within the USA
- Recall initiation date
- Aug 15, 2023
- Initial firm notification
- Letter
- Center classification date
- Aug 24, 2023